RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+25.77%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.05B
AUM Growth
+$4.05B
(+8.5%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
37.5%
Holding
124
New
3
Increased
35
Reduced
29
Closed
20
Top Buys
| 1 |
Eli Lilly
LLY
|
$40.5M |
| 2 |
Celldex Therapeutics
CLDX
|
$18.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$18.1M |
| 4 |
Immunovant
IMVT
|
$14.3M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$13.3M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.34% |
| 2 | Consumer Staples | 1.42% |
| 3 | Industrials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
51
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $22.9M | 0.56% | 120,000 -27,500 | -19% | -$5.24M |
|
52
Prothena Corp
PRTA
$441M
| $22.7M | 0.56% | 625,048 +10,750 | +2% | +$391K |
|
|
IMGN
53
DELISTED
Immunogen Inc
IMGN
| $22.5M | 0.55% | 759,365 | – | – |
|
|
NVRO
54
DELISTED
NEVRO CORP.
NVRO
| $22.1M | 0.54% | 1,025,000 -186,600 | -15% | -$4.02M |
|
55
Amgen
AMGN
$155B
| $21.5M | 0.53% | 74,500 +6,500 | +10% | +$1.87M |
|
56
Disc Medicine
IRON
$2.07B
| $21M | 0.52% | 363,468 | – | – |
|
57
Revolution Medicines
RVMD
$7.1B
| $20.8M | 0.51% | 725,152 | – | – |
|
58
Inspire Medical Systems
INSP
$2.77B
| $20.1M | 0.5% | 99,000 +54,500 | +122% | +$11.1M |
|
59
Immatics
IMTX
$619M
| $19.7M | 0.49% | 1,875,466 | – | – |
|
60
BioCryst Pharmaceuticals
BCRX
$1.74B
| $19.6M | 0.48% | 3,270,381 +719,155 | +28% | +$4.31M |
|
|
MREO
61
Mereo BioPharma
MREO
$272M
| $18.4M | 0.45% | 7,983,851 +307,370 | +4% | +$710K |
|
62
Collegium Pharmaceutical
COLL
$1.22B
| $17.3M | 0.43% | 562,000 | – | – |
|
|
INZY
63
DELISTED
Inozyme Pharma
INZY
| $15.7M | 0.39% | 3,681,174 | – | – |
|
64
Amicus Therapeutics
FOLD
$2.34B
| $15.1M | 0.37% | 1,063,806 | – | – |
|
65
BioMarin Pharmaceuticals
BMRN
$11.2B
| $14.4M | 0.35% | 148,832 -115,668 | -44% | -$11.2M |
|
|
ICVX
66
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $13.7M | 0.34% | 868,409 | – | – |
|
67
Krystal Biotech
KRYS
$4.27B
| $12.9M | 0.32% | 103,969 +13,409 | +15% | +$1.66M |
|
68
Structure Therapeutics
GPCR
$1.11B
| $11.7M | 0.29% | +286,676 | New | +$11.7M |
|
69
MacroGenics
MGNX
$112M
| $11.3M | 0.28% | 1,178,796 | – | – |
|
70
Mineralys Therapeutics
MLYS
$1.03B
| $10M | 0.25% | 1,167,492 | – | – |
|
71
Acumen Pharmaceuticals
ABOS
$82.4M
| $8.83M | 0.22% | 2,300,059 -512,520 | -18% | -$1.97M |
|
72
Compass Therapeutics
CMPX
$483M
| $8.6M | 0.21% | 5,513,788 | – | – |
|
73
Pulmonx
LUNG
$69.7M
| $8.32M | 0.2% | 652,400 | – | – |
|
74
Amylyx Pharmaceuticals
AMLX
$836M
| $7.88M | 0.19% | 535,012 -1,010,004 | -65% | -$14.9M |
|
|
SPRB
75
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $7.64M | 0.19% | 2,609,125 -119,000 | -4% | -$349K |
|